Comparing different radiofrequency modes for atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This trial tests three different ways of delivering radiofrequency energy using a specific catheter (QDOT) during a first-time procedure to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to find which method works best for patients with recent or short-lasting AF episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- This is your first procedure to treat atrial fibrillation
- Your atrial fibrillation episodes last less than 48 hours (paroxysmal) or between 7 days and 3 months (early persistent)
- You have had at least one AF episode in the past year
- You have health insurance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding a specific technique during a first-time catheter ablation for atrial fibrillation can improve safety or outcomes. It may help doctors understand risks related to small blood clots during the procedure.
This study tests if a new type of energy called pulse field ablation (a procedure that uses short bursts of electric pulses) works as well as standard ablation for restoring normal heart rhythm in patients with episodes of irregular heartbeat. It may help your heart pump more normally.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
This study compares a newer, faster type of ablation (high-power short-duration) with the standard approach for treating atrial fibrillation. The goal is to see which method is safer and more effective at restoring a normal heart rhythm.
This trial compares a newer type of ablation (pulsed field) with the standard radiofrequency ablation for people with persistent atrial fibrillation that hasn't been treated with ablation before. The goal is to see which method works better and has fewer risks.
This study tests a new system (QDOT MICRO and VISITAG SURPOINT) used during a catheter ablation procedure to treat atrial fibrillation (AF). It aims to see how safe and effective it is over the long term for people whose AF comes and goes and hasn't been controlled by medication.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.